Considering the specific expression of SGLT2 in the proximal tubules, previous studies about DN mainly focused on its beneficial effects by maintaining normal glycemia, thereby delaying DN progression (Kim et al., 2021; Sen et al., 2022). The gene discussed is SLC5A2; the disease is liver dysplastic nodule.